These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 6978891)

  • 1. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
    Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
    J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
    Minota S; Winfield JB
    J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
    Litvin DA; Cohen PL; Winfield JB
    J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.
    Glinski W; Gershwin ME; Steinberg AD
    J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus sera inhibit antigen presentation by macrophages to T cells.
    Brozek CM; Hoffman CL; Savage SM; Searles RP
    Clin Immunol Immunopathol; 1988 Feb; 46(2):299-313. PubMed ID: 3257427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
    Starkebaum G; Arend WP
    J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of immunoglobulin G from patients with systemic lupus erythematosus on human B cell function.
    Ramirez F; Searles RP; Williams RC
    Clin Immunol Immunopathol; 1987 Aug; 44(2):219-34. PubMed ID: 3111767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL; Stillman WS
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotype and cytotoxicity spectra of anti-lymphocyte antibodies in patients with systemic lupus erythematosus.
    Edwards BS; Searles RP; Brozek CM; Richards R; Savage SM; Nolla H; Hoffman CL
    Clin Immunol Immunopathol; 1987 Dec; 45(3):333-47. PubMed ID: 3315337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ia reactivity in sera from patients with systemic lupus erythematosus.
    Okudaira K; Searles RP; Ceuppens JL; Goodwin JS; Williams RC
    J Clin Invest; 1982 Jan; 69(1):17-24. PubMed ID: 6947981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
    Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
    Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte (macrophage)-specific antibodies in patients with systemic lupus erythematosus (SLE).
    Shirakawa F; Yamashita U; Suzuki H
    J Clin Immunol; 1987 Mar; 7(2):121-9. PubMed ID: 3571434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
    Sagawa A; Abdou NI
    J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of IgG anti-lymphocyte autoantibody-reactive molecules shed from activated T cells in systemic lupus erythematosus.
    Minota S; Winfield JB
    Rheumatol Int; 1988; 8(4):165-70. PubMed ID: 3055216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T gamma rosette formation by the sera from patients with systemic lupus erythematosus. Relation to T gamma-specific antilymphocyte antibody.
    Okudaira K; Tanimoto K
    Int Arch Allergy Appl Immunol; 1983; 71(4):346-51. PubMed ID: 6602775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.